Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2020

Dec 16, 2020

31210_dirs_2020-12-16_b97013c8-eafa-4878-afcb-479b720d0fd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2020-12-14

Reporting Person: Getsinger Peter W (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-14 Stock Option to Purchase Common Stock $45.75 A 10000 Acquired 2030-12-14 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12000 Direct
Common Stock 212 Indirect
Common Stock 188 Indirect

Footnotes

F1: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock at an exercise price of $45.75. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021.

F2: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and

F3: (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.